Loading...
Loading...
India's tofacitinib imports from UNITED STATES total $2.8M across 97 shipments from 15 foreign suppliers. PHARMACEUTICALS BUYERS INC leads with $750.5K in import value; the top 5 suppliers together control 62.0% of this origin. Leading Indian buyers include AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for tofacitinib — a diversified sourcing base with multiple active suppliers from UNITED STATES.

PHARMACEUTICALS BUYERS INC is the leading Tofacitinib supplier from UNITED STATES to India, with import value of $750.5K across 2 shipments. The top 5 suppliers — PHARMACEUTICALS BUYERS INC, ESPEE BIOPHARMA & FINECHEM LLC, NewLife Medicals (USA). Inc., M/S ESPEE BIOPHARMA & FINECHEM LLC, ESPEE BIOPHARMA & FINECHEM LLC. — collectively account for 62.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PHARMACEUTICALS BUYERS INC | $750.5K | 2 | 26.8% |
| 2 | ESPEE BIOPHARMA & FINECHEM LLC | $498.1K | 13 | 17.8% |
| 3 | NewLife Medicals (USA). Inc. | $225.7K | 6 | 8.1% |
| 4 | M/S ESPEE BIOPHARMA & FINECHEM LLC | $137.4K | 1 | 4.9% |
| 5 | ESPEE BIOPHARMA & FINECHEM LLC. | $126.3K | 6 | 4.5% |
| 6 | M/S. CALIGOR OPCO, LLC DBA | $125.3K | 2 | 4.5% |
| 7 | ESPEE BIOPHARMA FINECHEM LLC | $114.1K | 2 | 4.1% |
| 8 | Espee Biopharma Finechem LLC | $110.4K | 1 | 3.9% |
| 9 | PHARMACEUTICAL BUYERS,INC. | $85.3K | 3 | 3.0% |
| 10 | CALIGOR OPCO, LLC DBA | $79.0K | 1 | 2.8% |
| 11 | Espee Biopharma & Finechem LLC | $68.0K | 2 | 2.4% |
| 12 | ALMAC CLINICAL SERVICES | $56.3K | 7 | 2.0% |
| 13 | Pharmaceutical Buyers, Inc. | $52.3K | 1 | 1.9% |
| 14 | AMSTERDAM PHARMA(APTEKA RX INC.) | $48.8K | 2 | 1.7% |
| 15 | AGRACE PHARMA | $48.3K | 2 | 1.7% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED | $785.4K | 3 | 28.0% |
| 2 | MSN LABORATORIES PRIVATE LIMITED | $363.1K | 7 | 13.0% |
| 3 | MICRO LABS LIMITED | $280.2K | 4 | 10.0% |
| 4 | MYLAN LABORATORIES LIMITED | $184.3K | 5 | 6.6% |
| 5 | ALKEM LABORATORIES LIMITED | $139.6K | 4 | 5.0% |
| 6 | HETERO LABS LIMITED | $131.8K | 2 | 4.7% |
| 7 | SANDOZ PRIVATE LIMITED | $126.7K | 2 | 4.5% |
| 8 | AJANTA PHARMA LIMITED | $125.4K | 2 | 4.5% |
| 9 | NOVARTIS HEALTHCARE PRIVATE LIMITED | $125.3K | 2 | 4.5% |
| 10 | DR.REDDY'S LABORATORIES LTD | $94.7K | 4 | 3.4% |
| 11 | PFIZER LIMITED | $91.6K | 9 | 3.3% |
| 12 | GLENMARK PHARMACEUTICALS LIMITED | $61.3K | 2 | 2.2% |
| 13 | AUROBINDO PHARMA LTD | $54.2K | 3 | 1.9% |
| 14 | ALKEM LABORATORIES LTD | $49.8K | 2 | 1.8% |
| 15 | MACLEODS PHARMACEUTICALS LTD | $48.3K | 2 | 1.7% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Tofacitinib suppliers from UNITED STATES to India include PHARMACEUTICALS BUYERS INC, ESPEE BIOPHARMA & FINECHEM LLC, NewLife Medicals (USA). Inc.. The leading supplier is PHARMACEUTICALS BUYERS INC with import value of $750.5K USD across 2 shipments. India imported Tofacitinib worth $2.8M USD from UNITED STATES in total across 97 shipments.
India imported Tofacitinib worth $2.8M USD from UNITED STATES across 97 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Tofacitinib sourced from UNITED STATES include AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED, MSN LABORATORIES PRIVATE LIMITED, MICRO LABS LIMITED. The largest buyer is AIZANT DRUG RESEARCH SOLUTIONS PRIVATE LIMITED with $785.4K in imports across 3 shipments.
The total value of Tofacitinib imports from UNITED STATES to India is $2.8M USD, across 97 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
97 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists